1. Home
  2. RDHL vs JXG Comparison

RDHL vs JXG Comparison

Compare RDHL & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • JXG
  • Stock Information
  • Founded
  • RDHL 2009
  • JXG N/A
  • Country
  • RDHL Israel
  • JXG China
  • Employees
  • RDHL N/A
  • JXG N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • JXG
  • Sector
  • RDHL Health Care
  • JXG
  • Exchange
  • RDHL Nasdaq
  • JXG Nasdaq
  • Market Cap
  • RDHL 3.9M
  • JXG 4.6M
  • IPO Year
  • RDHL N/A
  • JXG N/A
  • Fundamental
  • Price
  • RDHL $1.23
  • JXG $1.03
  • Analyst Decision
  • RDHL
  • JXG
  • Analyst Count
  • RDHL 0
  • JXG 0
  • Target Price
  • RDHL N/A
  • JXG N/A
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • JXG 525.9K
  • Earning Date
  • RDHL 08-28-2025
  • JXG 05-15-2025
  • Dividend Yield
  • RDHL N/A
  • JXG N/A
  • EPS Growth
  • RDHL N/A
  • JXG N/A
  • EPS
  • RDHL N/A
  • JXG 0.86
  • Revenue
  • RDHL $8,042,999.00
  • JXG $49,840,288.00
  • Revenue This Year
  • RDHL $381.91
  • JXG N/A
  • Revenue Next Year
  • RDHL N/A
  • JXG N/A
  • P/E Ratio
  • RDHL N/A
  • JXG $1.19
  • Revenue Growth
  • RDHL 23.17
  • JXG 56.53
  • 52 Week Low
  • RDHL $1.17
  • JXG $0.55
  • 52 Week High
  • RDHL $15.34
  • JXG $8.40
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • JXG N/A
  • Support Level
  • RDHL $1.17
  • JXG N/A
  • Resistance Level
  • RDHL $3.31
  • JXG N/A
  • Average True Range (ATR)
  • RDHL 0.31
  • JXG 0.00
  • MACD
  • RDHL -0.09
  • JXG 0.00
  • Stochastic Oscillator
  • RDHL 2.80
  • JXG 0.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About JXG JX Luxventure Limited Common Stock

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.

Share on Social Networks: